Answers are grounded in this paper and cite their sources.
Review outlines improvements in pacing safety and efficacy in complex congenital heart disease using new technology.
Pacing in complex congenital heart disease can be difficult and with significant drawbacks due to issues with infection and long-term leads within the vasculature. Leadless pacemakers have emerged as a new technology with a strong safety and efficacy record in normal cardiac anatomy. Here, we review the current available technology, current evidence in complex congenital pacing and how leadless pacemakers may be used in complex congenital heart disease.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: